Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1166]
News [2570]
Articles [163]
Editorials [8]
Conferences [105]
elearning [18]
Quality of life and local treatment of oligometastatic prostate cancer
Prof Claude Abbou - Clinique de l'Alma, Paris, France
Quality of life and local treatment of oligometastatic prostate cancer ( Prof Claude Abbou - Clinique de l'Alma, Paris, France )
8 May 2019
Challenges in the treatment of upper urinary tract tumours
Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK
Challenges in the treatment of upper urinary tract tumours ( Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK )
8 May 2019
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019
Challenges to Jordanian Muslim men with prostate cancer
Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand
Challenges to Jordanian Muslim men with prostate cancer ( Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand )
8 May 2019
5' UTR mutations in prostate cancer
Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA
5' UTR mutations in prostate cancer ( Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA )
15 Apr 2019
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1...
Dr James Gulley - National Cancer Institute, Bethesda, USA
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )
15 Apr 2019
Risk factors for prostate cancer in men of African descent
Dr Faruk Mohammed - Ahmadu Bello University, Zaria, Nigeria
Risk factors for prostate cancer in men of African descent ( Dr Faruk Mohammed - Ahmadu Bello University, Zaria, Nigeria )
15 Apr 2019
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration...
Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas...
GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer (1/2) ( Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steuber )
10 Apr 2019
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)
GU Debates 2019: Practice-changing developments in urothelial cancer (2/2) ( )
9 Apr 2019
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate...
Prof Karim Fizazi, Dr Eleni Efstathiou
ASCO GU 2019: Treatment and management of hormone-sensitive metastatic prostate cancer ( Prof Karim Fizazi, Dr Eleni Efstathiou )
15 Mar 2019
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma
Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma ( Dr Stefanie Fischer - The Christie NHS Foundation Trust, Manchester, UK )
19 Feb 2019
KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non...
Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA
KEYNOTE-427 cohort B: First-line pembrolizumab monotherapy for advanced non-clear cell renal cell carcinoma ( Prof David McDermott - Beth Israel Deaconess Medical Center, Boston, USA )
19 Feb 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation